Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Commodities
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
Indiva Reports Fiscal Year 2023 Results Including Record Positive EBITDA and Income (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Palisade Bio Inc
PALI
Healthcare
Palisade Bio, Inc. is a biopharmaceutical company focused on developing therapeutics that protect the integrity of the intestinal barrier. The Company’s approach is founded on the discovery that damage to the intestinal epithelial barrier can result in the leakage of digestive enzymes from the gastrointestinal (GI) tract into the peritoneal cavity, which can damage tissues and promote...
inflammation, causing a broad array of acute and chronic conditions. Its lead therapeutic candidate, LB1148, is an oral liquid formulation of the well-characterized digestive enzyme inhibitor tranexamic acid (TXA), which is being developed for administration prior to surgeries that are at risk of disrupting the intestinal epithelial barrier. LB1148 is formulated as an aqueous solution for oral (enteral) administration. In addition to TXA, the LB1148 formulation contains polyethylene glycol, carbohydrates, and electrolytes.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NDAQ:PALI)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
Next
(57)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Apr 08, 2024 12:21pm
PALI.....offered at $6.49....hmmmm....
Sounds like a Lottery ticket to me ; ) And it's a winning ticket GLTU
(57)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Apr 08, 2024 12:08pm
PALI.....never know what this could do ; )
1st day being post RS Looks set up to me .....$6 Super thin
Indiva Reports Fiscal Year 2023 Results Including Record Positive EBITDA
posted Apr 25, 2024 9:00am by
Indiva Ltd
-
|
“Net Income was just shy of break-even in Q4, which is a testament to the popularity of our products, our industry leading low-cost production platform, and our focus on cost control. Our core brands, namely Pearls by Grön, No Future, Bhang Chocolate and Indiva Blips continue to gain market share in Canada, as Indiva continues to hold the #1 market share position in edibles nationally," said ...read more
(83)
•••
whytestocks
X
View Profile
View Bullboard History
Post by
whytestocks
on Feb 08, 2024 11:00pm
Palisade Bio Announces Formation of Clinical Advisory Board
News; $PALI Palisade Bio Announces Formation of Clinical Advisory Board with Appointments of Preeminent Key Opinion LeadersBruce Sands, MD, MS., Dr. Burrill B. Crohn Professor of Medicine, Icahn
...more
(83)
•••
whytestocks
X
View Profile
View Bullboard History
Post by
whytestocks
on Jan 29, 2024 12:30pm
Dow Edges Lower; Cardlytics Shares Jump | Benzinga
Just In: $PALI Dow Edges Lower; Cardlytics Shares Jump | BenzingaU.S. stocks traded mixed midway through trading, with the Nasdaq Composite gaining around 20 points on Monday.The Dow traded down 0.04%
...more
(83)
•••
whytestocks
X
View Profile
View Bullboard History
Post by
whytestocks
on Jan 29, 2024 10:00am
Palisade Bio Announces Positive Preclinical Data of Lead Pro
News; $PALI Palisade Bio Announces Positive Preclinical Data of Lead Program PALI-2108 at the 2024 Crohn's & Colitis Congress@ Preclinical data demonstrated PALI-2108 to be safe and well
...more
(7)
•••
Chart1
X
View Profile
View Bullboard History
Post by
Chart1
on Sep 29, 2023 1:46am
Bought in to this pos
The company is a disaster. Purely a trade for me here. A postion average at 0.54 . These dummies will pump this again to raise more money. I'll be exiting when they do. All these companies follow
...more
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Sep 11, 2023 4:01pm
New Press Release - Palisade Bio Announces Closing of $2 Million Registered Direct Offering Priced At Market Under Nasdaq Rules
Carlsbad, CA, Sept. 11, 2023 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI), a biopharmaceutical company advancing therapies for acute and chronic gastrointestinal (GI) complications, is announcing today that it has closed its previously announced registered direct offering with...
read article.
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Sep 11, 2023 8:35am
New Press Release - Palisade Bio Appoints GI Clinical Expert and Biotech Entrepreneur Mitchell Jones, M.D., Ph.D. as Chief Medical Officer
Announces Awarding of Inducement Grant to New Chief Medical OfficerCarlsbad, CA, Sept. 11, 2023 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI) (“Palisade” or the “Company”), a biopharmaceutical company advancing therapies for acute and chronic gastrointestinal (GI) complications, today...
read article.
(57)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Sep 07, 2023 8:45am
PALI .... P.O just announced
Always remember....all these Shitco's want to raise money.....it's the name of the game.....bury all the unsuspecting with worthless paper. Welcome to all the new Bagholders
(57)
•••
Iseneschal
X
View Profile
View Bullboard History
Comment by
Iseneschal
on Sep 07, 2023 8:41am
RE:RE:PALI...Trading down 26 cents in the Pre-market open..duh ; )
Good ol MAW.V ....... 300,000,000 shares outstanding......fill yer boots Is this the way you promote by spamming everyones elses boards???? Good f'king luck
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Sep 07, 2023 8:30am
New Press Release - Palisade Bio Announces $2 Million Registered Direct Offering of Common Stock Priced At Market Under Nasdaq Rules
Carlsbad, CA, Sept. 07, 2023 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI), a biopharmaceutical company advancing therapies for acute and chronic gastrointestinal (GI) complications, is announcing today that it has entered into definitive agreements with institutional investors for the...
read article.
(57)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Sep 07, 2023 8:22am
PALI...Trading down 26 cents in the Pre-market open..duh ; )
Last at $1.18 on 775,000 shs traded this a.m. Close Prices Last 3 Months Price/volumes not adjusted for restructures Date Ex Sym Open
...more
(57)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Sep 06, 2023 1:26pm
PALI .....125 million shares have traded and
your only up ~ $0.76 cents Please tell me another story
(57)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Sep 06, 2023 12:19pm
PALI....here it is again after the pump to $2
$1.43 pivot....gonna get smashed wait for it
Prev
1
2
3
4
5
6
7
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Stage Set for Creation of a Leading Intermediate Gold Producer
Centurion Identifies High Quality Gold Target-Casa Berardi West Project; Acquires Additional Claims
Revive Therapeutics Announces Type C Meeting Request Granted by FDA for Clinical Study
Discover a Green Resources Stock Scoring Record Quarterly Growth
Two New Contracts Awarded Covering Five Onshore Fields Producing 3,000 bbl/d of Oil